Cervical Cancer Treatment Report 2024 - Asia-Pacific Set to Register CAGR of 7.1% During 2024-2030, Driven by Increased HPV Vaccine Coverage, Rising Cervical Cancer Rates & Government Initiatives
December 10, 2024 05:33 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Cervical Cancer Treatment - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cervical Cancer...
Metastatic Triple-Negative Breast Cancer (mTNBC) Pipeline Landscape Research 2024: Comprehensive Insights About 10+ Companies and 12+ Drugs
November 21, 2024 04:05 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
10 year 8 Major Market Bladder Cancer Epidemiology Forecasts 2023-2033
November 18, 2024 10:20 ET
|
Research and Markets
Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Bladder Cancer: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Bladder cancer (International Classification...
Small Cell Lung Cancer Therapeutics Market Forecast to Reach $10.87 Billion by 2028 Amid Advances in Early Detection and Treatment
February 19, 2024 04:38 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Small Cell Lung Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Growth in Small Cell Lung...
Analysis of AstraZeneca's IMFINZI (Durvalumab) for Treating Malignant Pleural Mesothelioma (MPM): Regulatory Landmarks, Market Expansion, Intellectual Property, Future Challenges - Forecast to 2032
January 30, 2024 07:19 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "IMFINZI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This comprehensive report...
Lung Cancer Therapeutics Market Size Worth USD 57.69 Billion in 2032 | Emergen Research
January 04, 2024 07:45 ET
|
Emergen Research
Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global lung cancer therapeutics market size was USD 28.00 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...
Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032
December 14, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Pemetrexed + Cisplatin Drug Insights and Market Forecasts 2019-2032: The Standard of Care Front Line Regimen for Malignant Pleural Mesothelioma
December 12, 2023 04:58 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
December 07, 2023 06:30 ET
|
Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
Germ Cell Tumor Market revenue to hit USD 122 Billion by 2035, says Research Nester
November 21, 2023 06:30 ET
|
Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global germ cell tumor market size is projected to grow at a CAGR of over 12% from 2024-2036. The market is expected to garner a revenue of USD 122...